Net Cash Provided by (Used in) Financing Activities in USD of Telesis Bio Inc. from 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Telesis Bio Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2020 to Q1 2024.
  • Telesis Bio Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was -$27K, a 50% decline year-over-year.
  • Telesis Bio Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $11.6M, a 156% increase from 2022.
  • Telesis Bio Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.51M, a 96.3% decline from 2021.
  • Telesis Bio Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $121M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Telesis Bio Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$27K -$9K -50% 01 Jan 2024 31 Mar 2024 10-Q 10 May 2024
Q1 2023 -$18K -$76K -131% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q1 2022 $58K -$9.53M -99.4% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q1 2021 $9.59M 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022

Telesis Bio Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.6M +$7.06M +156% 01 Jan 2023 31 Dec 2023 10-K 29 Mar 2024
2022 $4.51M -$117M -96.3% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024
2021 $121M +$121M 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023
2020 -$96K 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.